Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lea Wagmann

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Archives of Toxicology|August 28, 2021
Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systemsTanja M Gampfer, Lea Wagmann, Anouar Belkacemi, et al.
Drug Testing and Analysis|January 19, 2025
Comprehensive Qualitative Drug Screening in Emergency Toxicology Using an Automated LC-MS<sup>n</sup> System:Simultaneous Quantification of Relevant Drugs and Metabolites in Blood PlasmaSelina Hemmer, Maximilian Ninnig, Lea Wagmann, et al.
Archives of Toxicology|July 5, 2022
Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterasesLea Wagmann, Rebecca G Stiller, Svenja Fischmann, et al.
Analytica Chimica Acta|November 10, 2021
Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MSCathy M Jacobs, Michael Kunz, Felix Mahfoud, et al.
Therapeutic Drug Monitoring|July 11, 2025
Unveiling Cardiac Complications: A Case of Amisulpride Overdose Leading to Bradycardia, QT-Prolongation, and Torsade de Pointes TachycardiaMichael Kunz, Lea Wagmann, Michael Schuster, et al.
Analytical and Bioanalytical Chemistry|November 1, 2022
Closing the gap - development of an analytical methodology using volumetric absorptive microsampling of finger prick blood followed by LC-HRMS/MS for adherence monitoring of antihypertensive drugsCathy M Jacobs, Michael Kunz, Felix Mahfoud, et al.
Drug Testing and Analysis|September 7, 2018
Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidasesLea Wagmann, Simon D Brandt, Alexander Stratford, et al.
Analytical and Bioanalytical Chemistry|November 19, 2025
Optimizing multiomics sample preparation: comparative evaluation of extraction protocols for HepG2 cellsTilman F Arnst, Selina Hemmer, Claudia Fecher-Trost, et al.
Drug Testing and Analysis|October 14, 2022
In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate [QMMSB]) and (quinolin-8-yl 4-methyl-3-((propan-2-yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testingMatthias J Richter, Lea Wagmann, Pierce V Kavanagh, et al.
Metabolites|September 24, 2020
Comparison of Three Untargeted Data Processing Workflows for Evaluating LC-HRMS Metabolomics DataSelina Hemmer, Sascha K Manier, Svenja Fischmann, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Archives of Toxicology|August 28, 2021
Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systemsTanja M Gampfer, Lea Wagmann, Anouar Belkacemi, et al.
Drug Testing and Analysis|January 19, 2025
Comprehensive Qualitative Drug Screening in Emergency Toxicology Using an Automated LC-MS<sup>n</sup> System:Simultaneous Quantification of Relevant Drugs and Metabolites in Blood PlasmaSelina Hemmer, Maximilian Ninnig, Lea Wagmann, et al.
Archives of Toxicology|July 5, 2022
Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterasesLea Wagmann, Rebecca G Stiller, Svenja Fischmann, et al.
Analytica Chimica Acta|November 10, 2021
Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MSCathy M Jacobs, Michael Kunz, Felix Mahfoud, et al.
Therapeutic Drug Monitoring|July 11, 2025
Unveiling Cardiac Complications: A Case of Amisulpride Overdose Leading to Bradycardia, QT-Prolongation, and Torsade de Pointes TachycardiaMichael Kunz, Lea Wagmann, Michael Schuster, et al.
Analytical and Bioanalytical Chemistry|November 1, 2022
Closing the gap - development of an analytical methodology using volumetric absorptive microsampling of finger prick blood followed by LC-HRMS/MS for adherence monitoring of antihypertensive drugsCathy M Jacobs, Michael Kunz, Felix Mahfoud, et al.
Drug Testing and Analysis|September 7, 2018
Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidasesLea Wagmann, Simon D Brandt, Alexander Stratford, et al.
Analytical and Bioanalytical Chemistry|November 19, 2025
Optimizing multiomics sample preparation: comparative evaluation of extraction protocols for HepG2 cellsTilman F Arnst, Selina Hemmer, Claudia Fecher-Trost, et al.
Drug Testing and Analysis|October 14, 2022
In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate [QMMSB]) and (quinolin-8-yl 4-methyl-3-((propan-2-yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testingMatthias J Richter, Lea Wagmann, Pierce V Kavanagh, et al.
Metabolites|September 24, 2020
Comparison of Three Untargeted Data Processing Workflows for Evaluating LC-HRMS Metabolomics DataSelina Hemmer, Sascha K Manier, Svenja Fischmann, et al.
Pageof 8